MicroPort Scientific Corporation announced that its President of MPO business, Mr. Sahagun will depart the company to pursue other interests effected as of April 1, 2019. Mr. Sahagun's departure marks the end of a 3.5-year tenure as President during an important chapter of MPO's turnaround. During this interim period, the MPO business will be led by MPSC's COO, Ms. Glendy Wang, who has an over a 20-year track record and experience in orthopedic joints. Ms. Wang started the China Orthopedic business for Smith & Nephew, growing that business to an over $300 million revenue business.

The company also announced that its board proposed that the dividend was HKD 0.029 per share based on the dividend payout ratio of 25%, which is consistent with 2017.